
Loading, please wait...

Loading, please wait...

Protein homeostasis, or proteostasis, remains essential for maintaining skeletal muscle integrity throughout a patient's life. However, its disruption serves as a central feature of aging-related sarcopenia. Researchers now recognize that aging skeletal muscle proteostasis involves complex interactions within the ubiquitin-proteasome system (UPS). This system acts as the primary pathway for selective protein degradation in muscle fibers. Unfortunately, its regulation during physiological aging remains incompletely understood. Consequently, clinicians must look beyond traditional markers to understand how muscle mass declines in the elderly.
Most clinical studies focus on muscle-specific E3 ubiquitin ligases, particularly MuRF1 and MAFbx/atrogin-1. These enzymes serve as reliable molecular markers for muscle atrophy because they flag proteins for degradation. However, current evidence suggests that changes in E3 ligase expression do not consistently correspond to actual proteasome activity. This disconnect indicates a gap between ubiquitination signals and the proteolytic capacity of the aging muscle. Therefore, relying solely on these markers may lead to an incomplete assessment of muscle health.
Deubiquitinating enzymes (DUBs) represent a crucial yet poorly understood regulatory layer in muscle aging. While E3 ligases add ubiquitin tags to proteins, DUBs remove them, effectively reversing the signal for degradation. Furthermore, specific DUBs like USP19 and USP14 appear to be induced during various forms of muscle wasting. This multi-layered regulation suggests that aging skeletal muscle proteostasis is not just about increased degradation. Instead, it involves a complex dysregulation of the entire proteostasis network. Understanding how these enzymes balance protein turnover is vital for developing future therapies for sarcopenia.
A more integrated evaluation of all UPS components is required to fully understand protein turnover in aging tissue. Current evidence indicates that different muscles and conditions regulate these components in distinct ways. Moreover, sarcopenia prevalence in India ranges significantly, with some studies reporting rates as high as 39.2% among the elderly. Given this high burden, moving beyond single-marker interpretations is essential. Clinicians should consider the combined activity of E3 ligases, DUBs, and the proteasome itself when evaluating muscle loss.
The ubiquitin-proteasome system (UPS) is the main pathway responsible for identifying and degrading selective proteins to maintain muscle integrity and health.
There is often a disconnect between the signals sent by E3 ligases and the actual activity of the proteasome, meaning protein tagging does not always lead to immediate degradation.
DUBs are enzymes that remove ubiquitin tags from proteins. They act as a regulatory layer that can prevent protein degradation, but their dysregulation can contribute to muscle wasting.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This article examines how the multi-layered dysregulation of the ubiquitin-proteasome system (UPS) drives sarcopenia by disrupting muscle protein homeostasi...
3 months ago

A clinical comparison of extravascular and subcutaneous implantable cardioverter-defibrillators, detailing patient selection, pacing capabilities, and implantation nuances.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today